CoChat

Newly Identified Apolipoprotein AV Gene Predisposes to High Plasma Triglycerides in Familial Combined Hyperlipidemia

Ribalta, Josep, Figuera, Lídia, Fernández-Ballart, Joan, Vilella, Elisabet, Castro Cabezas, Manuel, Masana, Lluís, Joven, Jorge · 2002 · Clinical Chemistry
Cited by 131

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Familial combined hyperlipidemia (FCHL) is the commonest form of hereditary hyperlipidemia (1) (2). Its primary defect is increased secretion of hepatic triglyceride (TG)-rich apolipoprotein B (apo B)-containing particles (VLDL) (3) and impaired clearance of postprandial lipoproteins (4), which increases the number of circulating TG-rich lipoproteins. FCHL is present in up to 20% of survivors of myocardial infarction, and it is considered a significant genetic risk factor for developing cardiovascular disease (1) (5). The underlying genetic defect is unknown, although the disease has been linked to chromosomes 1 (6) and 11 (7). With regard to the latter, linkage has been identified in the AI-CIII-AIV cluster, encoded in chromosome 11q23-q24, which has been repeatedly associated with FCHL as a site involved in modulating expression of the disease (8) (9). This is in part explained by the role of apo C-III as a negative regulator of TG hydrolysis. Despite considerable effort, no functional variant has been detected that explains such modulatory action, and the search has been extended to the surrounding regions. In this context, the newly identified apo AV gene (APOAV) (10) (11), adjacent to the AI-CIII-AIV gene cluster and with a clear impact on TG metabolism in animals (10), becomes a candidate. Association of this gene with plasma TG concentrations has also been reported in humans (10). We have explored such an association in FCHL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/clinchem/48.9.1597

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 131

Metadata

Authors
Ribalta, J., Figuera, L., Fernández-Ballart, J., Vilella, E., Castro Cabezas, M., Masana, L., & Joven, J.
Venue
Clinical Chemistry
Published
2002-09-01
Volume
48
Issue
9
Pages
1597-1600
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W1909965669
Cited by
131
References
2
FWCI
11.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Newly Identified Apolipoprotein AV Gene Predisposes to High Plasma Triglycerides in Familial Combined Hyperlipidemia. https://app.cochat.ai/papers/10.1093/clinchem/48.9.1597
The paper
Ribalta, J., Figuera, L., Fernández-Ballart, J., Vilella, E., Castro Cabezas, M., Masana, L., & Joven, J. (2002). Newly Identified Apolipoprotein AV Gene Predisposes to High Plasma Triglycerides in Familial Combined Hyperlipidemia. Clinical Chemistry. https://doi.org/10.1093/clinchem/48.9.1597

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.